Abeona Therapeutics reduces board size to seven; Chairman moves director class for compliance

ABEONA THERAPEUTICS INC.

Board size decreased from nine to seven directors, effective at 2023 Annual Shareholder Meeting.
Chairman Michael Amoroso relinquished Class 2 seat and was appointed Class 1 director to maintain equal class sizes.
Amoroso's service is deemed continuous; no new compensatory arrangements were entered into.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.